Abbott Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
For the six months, sales was PKR 24,680.43 million compared to PKR 20,797.98 million a year ago. Revenue was PKR 24,680.43 million compared to PKR 20,797.98 million a year ago. Net income was PKR 1,780.01 million compared to PKR 3,281.99 million a year ago. Basic earnings per share from continuing operations was PKR 18.18 compared to PKR 33.52 a year ago.